Authors:
VALLURI S
FLEMING TP
LAYCOCK KA
TARLE I
GOLDBERG MA
GARCIAFERRER FJ
ESSARY L
PEPOSE JS
Citation: S. Valluri et al., IN-VITRO AND IN-VIVO EFFECT OF POLYHEXAMETHYLENE BIGUANIDE AGAINST OCULAR HERPES-SIMPLEX VIRAL-INFECTION, Investigative ophthalmology & visual science, 36(4), 1995, pp. 149-149
Citation: I. Tarle et Jm. Petrash, EVIDENCE FOR A ROLE IN SUBSTRATE-BINDING BY HISTIDINE-110 AT THE ACTIVE-SITE OF HUMAN ALDOSE REDUCTASE, Investigative ophthalmology & visual science, 35(4), 1994, pp. 2152-2152
Citation: Jm. Petrash et al., ALDOSE REDUCTASE CATALYSIS AND CRYSTALLOGRAPHY - INSIGHTS FROM RECENTADVANCES IN ENZYME STRUCTURE AND FUNCTION, Diabetes, 43(8), 1994, pp. 955-959
Citation: Dk. Wilson et al., REFINED 1.8-ANGSTROM STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT, Proceedings of the National Academy of Sciences of the United Statesof America, 90(21), 1993, pp. 9847-9851
Authors:
TARLE I
BORHANI DW
WILSON DK
QUIOCHO FA
PETRASH JM
Citation: I. Tarle et al., PROBING THE ACTIVE-SITE OF HUMAN ALDOSE REDUCTASE - SITE-DIRECTED MUTAGENESIS OF ASP-43, TYR-48, LYS-77, AND HIS-110, The Journal of biological chemistry, 268(34), 1993, pp. 25687-25693
Citation: Jm. Petrash et al., STRUCTURE-FUNCTION STUDIES OF RECOMBINANT HUMAN ALDOSE REDUCTASE - THE EFFECT OF CYSTEINE TO SERINE SUBSTITUTIONS ON CATALYTIC EFFICIENCY AND SUSCEPTIBILITY TO ENZYME OXIDATION, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1007-1007